You must be logged in to view archived videos.
Log In or CLICK HERE to Register for FREE

Email

Password

  

Forgot your password?

Don't Have a MoneyShow.com account?

Register Today!

Become a MoneyShow.com member and receive:

• Unlimited access to hundreds of Webcasts
• FREE investing and trading e-letters
• Faster registration for our live location shows
• Login and tracking info for your records
• FREE membership gifts

and much, much more!

 

• Speaker Detail
• 
  George Tidmarsh

  George Tidmarsh, PhD, has 22 years of experience in biotechnology, which include the successful clinical development of three FDA-approved drugs. Up until his appointment to La Jolla Pharmaceuticals, he served as the chief executive officer of Solana Therapeutics, Inc. Previously, Dr. Tidmarsh served as the chief executive officer of Horizon Pharma, Inc., (NASDAQ: HZNP), a company he founded in 2005. While at Horizon, he led all aspects of development of Duexis, which was approved by the FDA for the treatment of conditions such as osteoarthritis and rheumatoid arthritis. He also founded Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) and held senior positions at Coulter Pharmaceutical, Inc.
  

• DESCRIPTION
• Comments

 More Video on ALTERNATIVE INVESTMENTS  

TRADESHOW LOCATIONS

San Francisco

 • August 15 – 17, 2013

More Details  | Register FREE

Sponsored Links